Internal medicine

Radiology

Nuclear medicine

Gastroenterology

Fluid-attenuated inversion recovery

Magnetic resonance imaging

Surgery

Randomized controlled trial

Chemotherapy

Prednisone

Corticosteroid

Nasopharyngeal carcinoma

Bevacizumab

Methylprednisolone

Radiation therapy

Medicine

International Journal of Radiation Oncology*Biology*Physics

Studies have shown that addition of bevacizumab to corticosteroids improves outcome against radiation-induced brain necrosis (RN). Here, we aimed to evaluate the effectiveness and safety of bevacizumab monotherapy on RN in nasopharyngeal carcinoma (NPC) patients.

Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial